Navigation Links
Smith & Nephew's New DYONICS™ PLATINUM Series Shaver Blades Establish New Standard for Leading-edge Resection Performance

ANDOVER, Mass., Sept. 8, 2011 /PRNewswire/ -- Smith & Nephew (NYSE: SNN) (LSE: SN) today announced the launch of its innovative, single-use DYONICS PLATINUM Series Shaver Blades which deliver superior arthroscopic resection, debris evacuation and sharpness.

The removal of tissue, cartilage and bone is a fundamental component of any arthroscopic repair procedure. The more precise and efficient surgeons are with their technique, the better chance they have of preserving the maximum amount of healthy tissue -- critical to joint stability and to delivering a successful surgical outcome.

The first in a family of eighteen blades to incorporate our new PLATINUM technology are the DYONICS INCISOR™ Plus PLATINUM 4.5 mm Blade and the DYONICS BONECUTTER™ PLATINUM 5.5 mm Blade. Each is designed to deliver best-in-class performance for specific arthroscopy procedures.

  • The DYONICS INCISOR™ Plus PLATINUM 4.5 mm Blade is designed to address knee procedures including anterior cruciate ligament (ACL) reconstruction and complex meniscectomies - of which 2.5 million are performed annually. The INCISOR Plus PLATINUM Blade incorporates a precision sharpened, tooth-to-tooth design, allowing it to grab frayed scar tissue or cut thick targeted tendon tissue more efficiently than other competitive blades.
  • The DYONICS BONECUTTER™ PLATINUM 5.5 mm Blade is a multifunctional device designed to be used for subacromial decompression procedures in the shoulder and ACL reconstruction in the knee due to its ultra-aggressive resection of thick tissue and hard bone.

"The INCISOR Plus PLATINUM Blade provides the user with the ability to perform aggressive but controlled, precision soft tissue resection. These blades are a joy to use and take soft tissue resection to a new level." said Charles Brown Jr., MD, Abu Dhabi Knee & Sports Medicine Centre, UAE.

Sean Gallimore, Vice President of Arthroscopic Technology Marketing for Smith & Nephew commented, "As an innovator in arthroscopic resection, our goal is to continuously evolve performance and provide world-class solutions. Choosing the right blade is a very important clinical decision which is why we focus on incorporating leading-edge design, technology and materials. Our new DYONICS PLATINUM Series Shaver Blades are designed to raise the bar for resection performance and deliver superior results for surgeons, and ultimately their patients." News

The DYONICS brand helped pioneer mechanical resection for arthroscopy more than 30 years ago. Since that time, Smith & Nephew has introduced a wide array of technological innovations to the DYONICS product line in support of new arthroscopic techniques resulting in the most extensive portfolio of shaver blades and burrs in the industry.

™ Trademark of Smith & Nephew. Certain Marks Reg. U.S. Pat. & T.M. Off.


Joe Metzger
Smith & Nephew
(978) 749-1330

Phil Cowdy
Smith & Nephew
44 (0)20 7401 7646  

About Smith & Nephew

Smith & Nephew is a global medical technology business with global leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine, Trauma and Clinical Therapies. The Company has distribution channels, purchasing agents and buying entities in over 90 countries worldwide. Annual sales in 2010 were nearly $4.0 billion.

Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. In particular, statements regarding planned growth in our business and in our operating margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.

All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

SOURCE Smith & Nephew
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Upsher-Smith Laboratories Named Manufacturer of the Year by AmerisourceBergen Corporation
2. H. D. Smith Reorganizes National Leadership for Continued Focus on Regional Customer Needs; Support Company Growth
3. GlaxoSmithKline CEO and CFO Interviewed on Q2 2011 Results
4. PK Study Comparing Upsher-Smiths Extended-Release Topiramate Formulation (USL255) With Topamax® Published Online In Epilepsia
5. Upsher-Smith Laboratories Begins Phase III Study of Intranasal Midazolam for Rescue Treatment of Seizure Clusters in Epilepsy Patients
6. H. D. Smith Voices Support for the Fairness in Medicare Bidding Act
7. GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older
8. H. D. Smith Appoints Mark de Bruin Corporate Vice President Managed Care
9. GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
10. Smith & Nephew Inc. Acquires Privately-Held TENET Medical Engineering, Inc.; Premier Provider of Surgical Patient Positioning Equipment
11. Smith & Nephew Endoscopy Awarded $85 Million in Patent Infringement Case Against Arthrex, Inc.
Post Your Comments:
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from reveals that behind the tendency to set ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
Breaking Medicine News(10 mins):